Kidney disease increases the risk of cardiovascular events in patients with device-detected atrial fibrillation
A prespecified analysis of the NOAH-AFNET 6 trial investigated the impact of kidney function on cardiovascular outcome in patients with device-detected atrial fibrillation. Today, the findings were presented by AFNET board ...
Apr 13, 2026
0
4







